Maze Therapeutics Inc. (MAZE)
NASDAQ: MAZE
· Real-Time Price · USD
12.87
-0.47 (-3.52%)
At close: Jun 06, 2025, 3:59 PM
12.59
-2.18%
After-hours: Jun 06, 2025, 05:57 PM EDT
-3.52% (1D)
| Bid | 11.65 |
| Market Cap | 563.67M |
| Revenue (ttm) | 2.5M |
| Net Income (ttm) | -80.91M |
| EPS (ttm) | 0.07 |
| PE Ratio (ttm) | 183.86 |
| Forward PE | -4.02 |
| Analyst | Buy |
| Ask | 13.6 |
| Volume | 46,809 |
| Avg. Volume (20D) | 219,696 |
| Open | 13.48 |
| Previous Close | 13.34 |
| Day's Range | 12.78 - 13.48 |
| 52-Week Range | 6.71 - 17.00 |
| Beta | 1.85 |
About MAZE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MAZE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MAZE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-10.08%
Maze Therapeutics shares are trading lower on poss...
Unlock content with
Pro Subscription
3 months ago
-2.31%
Maze Therapeutics shares are trading higher after JP Morgan initiated coverage on the stock with an Overweight rating and announced a price target of $30. Additionally, Leerink Partners initiated coverage on the stock with an Outperform rating and announced a price target of $28.
4 months ago · seekingalpha.com
U.S. IPO Weekly Recap: Active January Closes Out With Several Sizable IPOsFive IPOs listed this week, all of which raised over $100 million; one direct listing and three SPACs also debuted. Four microcaps submitted initial filings this week - Vistek, Awaysis Capital, QMSK T...